Stifel Financial Corp Avid Bioservices, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 16,892 shares of CDMO stock, worth $207,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,892

Previous 16,892 -0.0%

Holding current value

$207,771

Previous $120,000 60.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$6.34 - $9.28 $15,678 - $22,949	-2,473 Reduced 12.77%	16,892 $120,000
Q1 2024 May 13, 2024	SELL	$5.86 - $8.79 $6,944 - $10,416	-1,185 Reduced 5.77%	19,365 $129,000
Q4 2023 Feb 12, 2024	SELL	$4.64 - $9.56 $23,896 - $49,234	-5,150 Reduced 20.04%	20,550 $133,000
Q3 2023 Nov 13, 2023	BUY	$9.4 - $14.04 $141,940 - $212,004	15,100 Added 142.45%	25,700 $242,000
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $137,376 - $221,858	10,600 New	10,600 $148,000
Q4 2019 Feb 13, 2020	SELL	$5.01 - $8.16 $174,889 - $284,849	-34,908 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$5.07 - $7.08 $1,226 - $1,713	-242 Reduced 0.69%	34,908 $170,000
Q2 2019 Aug 14, 2019	SELL	$3.43 - $5.6 $3,423 - $5,588	-998 Reduced 2.76%	35,150 $180,000
Q1 2019 May 14, 2019	SELL	$3.56 - $4.82 $2,947 - $3,990	-828 Reduced 2.24%	36,148 $139,000
Q4 2018 Feb 13, 2019	SELL	$4.04 - $6.75 $578,701 - $966,890	-143,243 Reduced 79.48%	36,976 $139,000
Q3 2018 Nov 13, 2018	SELL	$4.28 - $7.32 $36,923 - $63,149	-8,627 Reduced 4.57%	180,219 $1.24 Million
Q2 2018 Aug 14, 2018	SELL	$3.1 - $3.93 $5,421 - $6,873	-1,749 Reduced 0.92%	188,846 $747,000
Q1 2018 May 11, 2018	BUY	$2.32 - $4.22 $442,180 - $804,310	190,595 New	190,595 $555,000

Others Institutions Holding CDMO

# of Institutions

183

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $765M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Avid Bioservices, Inc. Transaction History